Good Distribution Practice (GDP) forms part of quality assurance and ensures that medicinal products are consistently stored, transported, and handled under suitable conditions, maintaining their quality, integrity, and traceability throughout the distribution chain. GDP plays a critical role in protecting patient safety and maintaining confidence in the legal supply chain.
While GDP is primarily established for the pharmaceutical supply chain, its underlying principles of controlled storage, handling, transport, and documentation are also widely applied to healthcare distribution operations, including medical device storage and logistics environments.
The Basics you may want to know!
Distribution activities for medicines and healthcare products involve multiple parties and inherent risks at various stages, including procurement, storage, relabelling, transportation, and delivery. GDP provides a structured framework to control these risks and ensure products remain suitable for use throughout distribution.
At its core, GDP requires organizations to implement a documented quality system for distribution, supported by management commitment and trained personnel. The system must define responsibilities, procedures, records, and controls to ensure that distribution activities do not compromise product quality or integrity.
Key technical elements of a GDP-aligned system typically include:
- A distribution quality management system covering procedures, records, deviation management, CAPA, change control, and management review
- Defined roles and responsibilities, including oversight of distribution activities and escalation of quality issues
- Controlled premises and storage conditions, including environmental controls appropriate to product requirements
- Temperature monitoring and control, supported by risk-based temperature mapping and calibrated monitoring equipment
- Supplier, contractor, and customer approval processes to maintain supply-chain integrity
- Controls for complaints, returns, recalls, and prevention of product diversion or mix-ups
Although GDP requirements are most clearly defined for pharmaceutical products, similar good storage and distribution principles are increasingly expected across regulated healthcare supply chains, including medical device warehousing and logistics operations.
GDP Implementation & Compliance Support: How Maqlink IMC can help you
Maqlink IMC provides expert consultancy support to help organizations design, implement, and maintain GDP-aligned distribution quality systems that are practical, scalable, and aligned with regulatory and customer expectations.
Our focus is on building systems that are fit for purpose, operationally efficient, and capable of standing up to regulatory inspections and customer audits.
We offer online and onsite consultancy services as per customer requirement, including:
- Gap analysis against applicable GDP and distribution control expectations
- Training for awareness, documentation, operations, and internal auditing
- Documentation establishment, including SOPs, records, risk assessments, and quality agreements
- Implementation assistance, covering rollout of controls, responsibilities, and monitoring systems
- Cold chain and environmental control support, including temperature monitoring strategy and excursion management
- Inspection and audit readiness support, including mock audits and CAPA closure
- Ongoing maintenance services to support continual compliance and improvement
Our services are particularly suited to:
- Pharmaceutical wholesalers and distributors
- Healthcare logistics providers and 3PLs
- Organizations managing controlled storage and distribution of regulated healthcare products, including medical devices
Benefits of implementing GDP in your Organization
Effective implementation of GDP helps organizations maintain product quality throughout
distribution while strengthening governance and customer confidence.
Key benefits include:
-
Reduced risk of product quality loss during storage and transportation
-
Stronger control over supply-chain integrity and traceability
-
Improved readiness for regulatory inspections and customer audits
-
Enhanced control of temperature-sensitive and high-risk products
-
Faster investigation and resolution of deviations, complaints, and returns
-
Improved customer confidence and reputation as a reliable distribution partner
-
Clearer roles, responsibilities, and communication across distribution operations
FAQs – GDP Good Distribution Practices
GDP helps maintain control of the distribution chain, reduces the risk of product deterioration or diversion, and supports patient safety by ensuring that products reaching end users remain suitable for use.
GDP is essential for pharmaceutical wholesalers and distributors, and is also relevant to healthcare logistics operations handling regulated products that require controlled storage, handling, and traceability.
GDP is primarily established for the pharmaceutical supply chain. However, similar good storage and distribution principles are applied in other regulated sectors depending on product type and applicable regulations. For medical devices and healthcare products, distribution controls typically focus on storage conditions, handling, transport, traceability, and prevention of quality loss. In the food sector, equivalent distribution requirements are addressed through food hygiene, HACCP-based prerequisite programs, and supply-chain control practices rather than pharmaceutical GDP legislation.
If your organization stores, transports, or distributes pharmaceutical products, you
typically need GDP controls to ensure products are consistently handled under suitable
conditions and integrity is maintained throughout distribution.
If your organization is involved in the medical device lifecycle (e.g., design, production,
storage/distribution, installation, servicing), then ISO 13485 is the appropriate quality
management system standard, as it is specific to medical devices and intended to support
meeting applicable regulatory requirements.
In many cases, organizations dealing with both pharmaceuticals and medical devices
implement both—GDP for distribution controls of medicines and ISO 13485 for a
device-specific QMS covering lifecycle and quality controls.
